10-03-2023, 06:48

FDA Advisory Committee votes in favour of the clinical

U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX
Globe Newswire10-03-2023, 06:48
23-02-2023, 13:08

Roche launches two new antibodies to identify key clinical

Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations in
Globe Newswire23-02-2023, 13:08
10-02-2023, 13:07

[Ad hoc announcement pursuant to Art. 53 LR] Transaction in

Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation
Globe Newswire10-02-2023, 13:07
1-02-2023, 13:17

European Commission approves label expansion of Roche’s

Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient
Globe Newswire1-02-2023, 13:17